Researchers develop AI tool to predict bowel cancer patients' drug responses

Researchers at London's Institute of Cancer Research have developed an AI tool, PhenMap, to predict responses to the NHS drug bevacizumab in bowel cancer patients. The study involved 117 patients and aims to spare thousands from ineffective treatments. With nearly 10,000 advanced bowel cancer cases annually in the UK, this breakthrough could significantly impact patient.

Read full article on The Guardian Australia →

Summary by Glance · Original reporting by The Guardian Australia